300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Retail
Oil and Gas
Film
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Medical
Web3
Recruiting
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Singapore
Burkina Faso
Africa
LATAM
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Côte d'Ivoire
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
New Zealand
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 35 Biotechnology Angel Investors in Singapore (November 2026)

The most active angel investors investing in Singapore Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Paul Buchheit
Angel
2 United States, Canada, India Seed, Series A, Angel Software, SaaS, Health Care $100k–$14M
Tak Wai Chung
Angel
2 Singapore Seed, Angel Food Processing, Waste Management
Kuldeep Rajput
Angel
2 Singapore Pre-Seed, Series A Life Science, Biotechnology
Te Ling Nai
Angel
2 Singapore Seed, Angel Food Processing, Waste Management
Leo Lozner
Angel
1 Estonia, Singapore, Switzerland Angel, Pre-Seed, Series A Sports, Farming, Fitness $500k–$600k
John Ballantyne
Angel
1 United States, Singapore Seed, Series A, Angel Health Care, Biotechnology, Therapeutics $4.5M–$30M
Xiangliang Lin
Angel
1 Singapore, United Kingdom Seed Medical, Biopharma, Health Care
Benjamin Boyer
Angel
1 United States, China, Germany Series C, Seed, Series B Internet, Software, E-Commerce $1.2M–$256M
Siu Rui Quek
Angel
1 Singapore, Indonesia Seed, Pre-Seed, Series A Health Care, Education, Information Technology $260k–$7.6M
Adam Niewinski
Angel
1 Poland, Singapore, United States Series A, Seed, Series B FinTech, Artificial Intelligence, Financial Services $1M–$65M
Wendou Niu
Angel
1 Singapore Series A Life Science, Biotechnology
Alice Foo
Angel
1 Singapore Pre-Seed Recycling, Biotechnology, Waste Management
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Medical $493k–$2.8M
Nadav Rosenberg
Angel
1 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$21M
Feng Hu
Angel
1 United States, India, Singapore Seed, Pre-Seed, Convertible Note Communities, Mobile Apps, CRM $1.3M–$1.4M
Kane Black
Angel
1 Singapore Angel Medical, Genetics, Health Diagnostics
Chang Kim
Angel
1 United States Pre-Seed, Seed, Series A Gaming, Ad Network, Loyalty Programs $1.3M–$2.8M
Vichit Suraphongchai
Angel
1 Singapore Seed, Pre-Seed Medical, Health Care, Biotechnology
Jack Wang
Angel
1 Singapore Seed Fertility, Biotechnology, Medical Device
Gireesh Narsimhan
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Buddhadeb Biswas
Angel
1 Singapore Seed mHealth, Health Care, Biotechnology
Ravindran Govindan
Angel
1 Singapore Seed mHealth, Health Care, Biotechnology
Kurt Heinrichs
Angel
1 Singapore Seed Medical, Health Care, Biotechnology
Y S Shashidhar
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Raman Singh
Angel
1 Singapore Series A Life Science, Biotechnology
Idgar Van Kippersluis
Angel
1 Singapore Seed AgTech, Agriculture, Animal Feed
Johannes Hille
Angel
1 Singapore Seed Medical, Health Care, Biotechnology
Frederik Vandermarlie
Angel
1 Belgium, Singapore Seed Medical, Legal Tech, Health Care $2.3M–$4M
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology $1.1M–$1.9M
Jeffrey Tiong
Angel
1 Singapore Pre-Seed, Seed Health Care, Information Technology, Artificial Intelligence $738k–$4M
Claudia Zeisberger
Angel
1 Singapore Seed AgTech, Agriculture, Animal Feed
Roy Oron
Angel
1 Israel, United States, Singapore Seed, Series A, Pre-Seed Software, Artificial Intelligence, Mobile $300k–$1.5M
Frank Ulmer
Angel
1 Singapore Seed Medical, Health Care, Biotechnology
Ron Sim
Angel
1 Singapore Series A Beauty, Fitness, Genetics
Evan DiMeglio
Angel
1 United States, Canada, Singapore Seed, Pre-Seed, Series B Software, E-Commerce, Gaming $3.2M–$4M
Access all 35 angel investors in Singapore Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Paul Buchheit
Angel · Mountain View, California, United States · 2 investments in Singapore Biotechnology startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 167
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — We build products that feel personal, magical and deeply human
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Tak Wai Chung
Angel · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Singapore Biotechnology startups

Tak Wai CHUNG joined EQT Partners in February 2009 as a Vice President.Tak Wai holds a Bachelor of Arts degree in Molecular Biology and Biochemistry and Mathematics-Economics from Wesleyan University (High Honors, Phi Beta Kappa), and a Master of Business Administration degree from the Tuck School of Business at Dartmouth.Prior to joiningEQT Partners, Tak Wai was with Lehman Brothers for over six years. While at Private Equity in Hong Kong, he focused on making direct investments into China. Before that, he was in the Investment Banking division covering primarily telecommunications, financial institutions and natural resources in both New York and Hong Kong.Tak Wai is a member of the Mid Market Partners Investment Committee and the Greater China II Internal Investment Committee.

Show more...

Investment focus

  • Industry: Food Processing, Waste Management
  • Stage:Seed, Angel
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Show all investments...

Kuldeep Rajput
Angel · 2 investments in Singapore Biotechnology startups

Founder & CEO @ Biofourmis

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Pre-Seed, Series A
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Te Ling Nai
Angel · 2 investments in Singapore Biotechnology startups

Te-Ling Nai is an individual investor.

Show more...

Investment focus

  • Industry: Food Processing, Waste Management
  • Stage:Seed, Angel
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Show all investments...

Leo Lozner
Angel · 1 investments in Singapore Biotechnology startups

Investment focus

  • Industry: Sports, Farming, Fitness
  • Stage:Angel, Pre-Seed, Series A
  • Geography: Estonia, Singapore, Switzerland

Investor stats

  • Total investments: 4
  • Round size: Angel $500k–$600k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DEIP — DEIP provides a set of Web 3.0 protocols, tools, and applications for the creative economy. The core protocol is Web 3.0 protocol for Intellectual Capital.DEIP Protocol (or Intellectual Capital Protocol) is a decentralized protocol that allows discovering, evaluation, licensing, and exchange of intangible assets, designed specifically forintangible assets tokenization (as F-NFT), governance (via DAO), and liquidity (via DeFi instruments and derivatives).DEIP Network is an application-specific Polkadot Parachain built with Substrate 3.0 Framework and implements various creative economy protocols: the core protocol is Intellectual Capital Protocol, and on top of it the network implements Collective Intelligence Protocol, Dynamic Liquidity Protocol, and others.
  • Gero — Utilizing whole-exome sequencing data for in-human AI drug discovery
  • Zenia — Thanks to Zenia, yoga beginners now have easier and more affordable access to dive into yoga at home and practice with all the information they need. We believe nothing looks as good as healthy feels.Safety first. We’ve built Zenia to be a guide that adapts to your pace, monitors the progress, and gives gentle corrections. Whether you want tostart yoga, build strength, get in shape, feel better, or be inspired, the app will help you to achieve your goals.Easy. Safe yoga practice doesn’t need to happen at an offline yoga studio. You can access the Zenia studio online from the comfort of your home and, while you’re at it, get instant feedback from your teacher.
Show all investments...

John Ballantyne
Angel · Fargo, North Dakota, United States · 1 investments in Singapore Biotechnology startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Angel
  • Geography: United States, Singapore

Investor stats

  • Total investments: 11
  • Round size: Seed $4.5M–$7M; Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — AI-native platform for regulated, high-stakes environments. Purpose-built to solve the hardest integration and workflow problems where compliance isn't optional.
  • GlucoTrack — We are pleased to announce that the diabetes technology business focused on developing our Continuous Blood Glucose Monitor (CBGM) platform will now operate
Show all investments...

Xiangliang Lin
Angel · 1 investments in Singapore Biotechnology startups

Xiangliang Lin

Show more...

Investment focus

  • Industry: Medical, Biopharma, Health Care
  • Stage:Seed
  • Geography: Singapore, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MFX — Delivering the next generation of automated cell and gene therapy manufacturing platforms to bring precision medicine to patients
  • ImpacFat — ImpacFat is a food production company that develops fish meat alternatives through cell cultivation.
Show all investments...

Benjamin Boyer
Angel · San Francisco, California, United States · 1 investments in Singapore Biotechnology startups

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000. Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments. Ben holds an M.B.A. from Stanford Graduate School of Business and a B.S. in human and organizational development from Vanderbilt University.

Show more...

Investment focus

  • Industry: Internet, Software, E-Commerce
  • Stage:Series C, Seed, Series B
  • Geography: United States, China, Germany

Investor stats

  • Total investments: 30
  • Round size: Seed $1.2M–$4.4M; Series B $12M–$256M; Series C $10M–$110M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
  • People.ai — Uncover the Fastest Path to Revenue
  • Triparound — All-in-one guest experience software for hotels and vacation rentals. Reduce admin time, streamline bookings, and grow ancillary revenue.
Show all investments...

Siu Rui Quek
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotechnology startups

Siu Rui Quek is the Co-founder and CEO of Carousell. Siu Rui previously worked at VSee as a Collaboration Evangelist. Siu Rui Quek attended the National University of Singapore. Siu Rui Quek has received the Asia's Most Influential Award, Outstanding Young Alumni Award, and Eminent Business Alumni Award.

Show more...

Investment focus

  • Industry: Health Care, Education, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Singapore, Indonesia

Investor stats

  • Total investments: 14
  • Round size: Seed $743k–$7.6M; Pre-Seed $260k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yolk.fm — Yolk.fm is a social platform that allows users to chat rather than send text messages.
  • Evo — Social Commerce Software
  • Circular — We are making subscriptions the best way to experience tech. Circular aims to accelerate the circular economy and maximise the useful lives of each tech device to its fullest potential.
Show all investments...

Adam Niewinski
Angel · Warsaw, Mazowieckie, Poland · 1 investments in Singapore Biotechnology startups

Adam Niewinski is based out of Warsaw, Mazowieckie, and is the Co Founder & General Partner of OTB Ventures. Adam previously worked at Xelion Investment House as the Chairman of the Supervisory Board. Adam Niewinski attended the SGH Warsaw School of Economics.

Show more...

Investment focus

  • Industry: FinTech, Artificial Intelligence, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: Poland, Singapore, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $1M–$12M; Series A $6.2M–$65M; Series B $8.8M–$34M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • Credolab — An alternative credit scoring solution based on alternative data (smartphone and web metadata)
  • Expander Polska — Expander is an independent financial advisor in Poland established in 2000. It started with an internet portal as the only distribution channel, evolving into a traditional branch network over years.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wendou Niu
Angel · 1 investments in Singapore Biotechnology startups

Co-founder & Chief Privacy Officer @ Biofourmis

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Alice Foo
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotechnology startups

Alice Foo is an angel investor for Alterpacks.

Show more...

Investment focus

  • Industry: Recycling, Biotechnology, Waste Management
  • Stage:Pre-Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AlterPacks — Alterpacks - New Materials Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.
Show all investments...

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in Singapore Biotechnology startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Medical
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $493k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 1 investments in Singapore Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Feng Hu
Angel · Wellington, Wellington, New Zealand · 1 investments in Singapore Biotechnology startups

Feng Hu

Show more...

Investment focus

  • Industry: Communities, Mobile Apps, CRM
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.3M–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
  • DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
  • Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Show all investments...

Kane Black
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotechnology startups

Kane Black is the founder of Severn Capital, a Singapore-headquartered principal investment and strategic transactions firm active across London, Asia and international capital markets. He has more than 20 years of operating, investment and corporate experience across Asia and international markets, spanning principal investment, public companies, healthcare, technology and cross-border transactions. His career has included building and leading businesses across Southeast and North Asia, executing acquisitions and strategic partnerships, and working with institutional, family-office and private capital. Kane previously served as Chief Executive of London Stock Exchange-listed Ikigai Ventures Limited (LON:IKIV), where he led the company through the acquisition of Dotlines Global (LON:DOTL) and the associated reverse takeover and readmission to the London market. He remains active across London public markets through the origination and execution of acquisitions, reverse takeovers, capital raisings and other strategic transactions. Earlier in his career, Kane held senior executive roles across the medical diagnostics sector in Singapore and the wider Asia-Pacific region, including Chief Executive roles at INEX Innovate and iGene Laboratory. During this period he led expansion across regional markets, strategic partnerships and corporate development initiatives. He was named EY Singapore Entrepreneur of the Year – Biotechnology in 2022. Kane is also a Non-Executive Director of INEX Innovate, a member of the NUS Medicine International Council and the Hong Kong Biotechnology Organisation. Through Severn Capital, he focuses on principal investment and strategic transactions involving public and private companies, with particular interests in natural resources, technology, healthcare and industrial businesses. The firm also works with companies and asset owners considering access to the London and Canadian public markets, including through acquisitions and reverse takeovers.

Show more...

Investment focus

  • Industry: Medical, Genetics, Health Diagnostics
  • Stage:Angel
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nova Satra Dx — Rooted in nature. Guided by science
Show all investments...

Chang Kim
Angel · San Francisco, California, United States · 1 investments in Singapore Biotechnology startups

Chang Kim is the CEO of Tapas Media.

Show more...

Investment focus

  • Industry: Gaming, Ad Network, Loyalty Programs
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $1.3M–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Luckmon — Luckmon Mobile Games Website Let's Play our games and collect gift card.
  • Noah's Farm — Bringing science and generative AI together to design new ingredients and formulations.
  • The Data Foundation — Story is AI-native infrastructure for the intellectual property economy.
Show all investments...

Vichit Suraphongchai
Angel · Bangkok, Krung Thep, Thailand · 1 investments in Singapore Biotechnology startups

CEO of Siam Commercial Bank. Formerly President of Bangkok Bank; Minister of Transport and Communications (Thailand); Director of Thai Airways; MEng Berkley, PhD UCLA

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
  • X-Zell Biotec —
Show all investments...

Jack Wang
Angel · 1 investments in Singapore Biotechnology startups

Jack Wang

Show more...

Investment focus

  • Industry: Fertility, Biotechnology, Medical Device
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Show all investments...

Gireesh Narsimhan
Angel · Pune, Maharashtra, India · 1 investments in Singapore Biotechnology startups

Gireesh Narsimhan

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Buddhadeb Biswas
Angel · San Jose, California, United States · 1 investments in Singapore Biotechnology startups

Buddhadeb Biswas is the Founder of 22North and the President and CEO of Polaris Networks. Bud attended the University of Michigan.

Show more...

Investment focus

  • Industry: mHealth, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Ravindran Govindan
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotechnology startups

Ravindran Govindan - Executive Chairman and founder @ Eight Mercatus

Show more...

Investment focus

  • Industry: mHealth, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Kurt Heinrichs
Angel · 1 investments in Singapore Biotechnology startups

Kurt Heinrichs

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
Show all investments...

Y S Shashidhar
Angel · 1 investments in Singapore Biotechnology startups

Y S Shashidhar

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Raman Singh
Angel · 1 investments in Singapore Biotechnology startups

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Idgar Van Kippersluis
Angel · 1 investments in Singapore Biotechnology startups

Distinguished Fellow @ INSEAD Distinguished Fellow @ INSEAD

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Animal Feed
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • INSEACT — Biotech company producing protein from black soldier fly insects
Show all investments...

Johannes Hille
Angel · 1 investments in Singapore Biotechnology startups

Johannes Hille is Chief Operations Officer at X-ZELL. He attended IBS International Business School.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
Show all investments...

Frederik Vandermarlie
Angel · 1 investments in Singapore Biotechnology startups

Frederik Vandermarlie

Show more...

Investment focus

  • Industry: Medical, Legal Tech, Health Care
  • Stage:Seed
  • Geography: Belgium, Singapore

Investor stats

  • Total investments: 2
  • Round size: Seed $2.3M–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
  • Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Show all investments...

Eric Urhane
Angel · 1 investments in Singapore Biotechnology startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Jeffrey Tiong
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotechnology startups

Jeffrey Tiong is the Founder & CEO of PatSnap. Jeffrey Tiong attended the National University of Singapore. Jeffrey Tiong has received the IT Leader Award 2019 SCS and EY Entrepreneur of the year 2018 Singapore.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed
  • Geography: Singapore

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $738k–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Formas.AI — The Best AI Orchestrator for Architecture, Interior Design & Spatial Planning. Sketch to Image, Instant Video Narratives, 3D Rendering, Vibe Architecture.
  • Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
  • StratifiCare — At StratifiCare, we focus on the development and manufacturing of IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With more than 50 years of cumulative in-depth experience in Biomedical R&D and technology commercialization, StratifiCare strives to empower personalised medicine.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Claudia Zeisberger
Angel · 1 investments in Singapore Biotechnology startups

Claudia Zeisberger is the Professor of Entrepreneurship & Family Enterprise, Founder & Academic Co-Director, Global Private Equity Initiative (GPEI) at INSEAD.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Animal Feed
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • INSEACT — Biotech company producing protein from black soldier fly insects
Show all investments...

Roy Oron
Angel · , , Israel · 1 investments in Singapore Biotechnology startups

Roy Oron is an early stage Tech/Biotech investor as well as the founder and general partner at ITI Venture Capital Partners.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Mobile
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Israel, United States, Singapore

Investor stats

  • Total investments: 22
  • Round size: Seed $300k–$1.5M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • 4M Analytics — 4M Analytics' unique Technology provides owners, consulting engineers, and contractors a complete, accurate, and up-to-date subsurface-infrastructure database.
  • Atlas Invest — A platform for institutional investors to invest in real estate backed bridge loans at scale with reduced risk.
  • EdiTy Therapeutics — EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020.
Show all investments...

Frank Ulmer
Angel · 1 investments in Singapore Biotechnology startups

Frank Ulmer

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
Show all investments...

Ron Sim
Angel · 1 investments in Singapore Biotechnology startups

Ron Sim

Show more...

Investment focus

  • Industry: Beauty, Fitness, Genetics
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Show all investments...

Evan DiMeglio
Angel · New York, New York, United States · 1 investments in Singapore Biotechnology startups

Evan DiMeglio

Show more...

Investment focus

  • Industry: Software, E-Commerce, Gaming
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United States, Canada, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $3.2M–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cyble — Cyble is a leading threat intelligence provider that obtains and processes data from the dark web and OSINT to mitigate external cybersecurity risks
  • TurtleTree — TurtleTree produces the world's first sustainable lactoferrin LF+ using precision fermentation. Animal-free, vegan-certified for food, beverages & supplements.
  • Triumph — Triumpharcade home page description
Show all investments...

Biotechnology Angel investor funding in Singapore at a glance

Stats across 24 deals from 35 investors.

35
investors
in Singapore Biotechnology startups
24
deals
in Singapore Biotechnology startups
$2.6M
median round
in Singapore Biotechnology startups
26%
lead investors
lead at least one round
42%
Seed
most common funding stage

Access all 35 angel investors in Singapore Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 35 angel investors investing in Singapore Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists